Our CSO and Cofounder Dr Jordan Lane spoke to Labiotech about how biotechs are using AI to rescue failed drugs.
“Historically, many AI companies have only focused on either cheminformatics or bioinformatics, but Ignota believes that it is the intersection of these two techniques that will unlock true insights into the drugs that have hit issues… giving us the belief that [a safety] problem is solvable, resulting in us in-licensing the project, developing the chemistry and bringing the drug to the clinic (or back to the clinic) as quickly as possible”
Read more:
‘How biotechs are using AI to rescue failed drugs,’ can be read in full at Labiotech.
Published: 17 March 2025 by Labiotech.
